Gilead partners with Tubulis to develop solid tumour ADC
The German drugmaker will receive an upfront payment of $20m, a separate option exercise fee of $30m, and is eligible to receive up to $415m in milestone payments, in addition...
Sanofi to invest €1bn in new insulin production base in Beijing
Enveric Biosciences receives two US patents for psilocybin derivatives
Rigel announces R289 granted fast track designation by FDA for lower-risk MDS
CBC, Mubadala complete acquisition of UCB’s mature business in China
UQ researchers get funding to develop topical skin cancer treatment
Analysis
View More
Risks
View MoreSocietal polarisation and its impact on the pharmaceutical industry
Societal polarisation presents significant challenges for the pharmaceutical industry, affecting regulatory landscapes, public trust, innovation, and market dynamics
Effects of interstate armed conflicts on the pharmaceutical industry
Unveiling the impact of misinformation and disinformation in the pharmaceutical industry
The ripple effects of inflation on the pharmaceutical industry
Extreme weather events: The implications for the pharmaceutical industry